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Regarding %Vhat you didn't  know about the 
NASCET" 
To the Editors: 
In a recent editorial (J VASC SURG 1995;25:163-5), 
Dr. Eugene Strandness raised several concerns about the 
data monitoring committee of the North American Symp- 
tomatic Carotid Endarterectomy Trial (NASCET). Be- 
cause of the importance of the trial and the seriousness of 
the concerns, I asked a group of four consultants (one from 
the National Heart, Lung, and Blood Institute and three 
from outside of the National Institutes of Health) to meet 
and review the procedures used by the National Institute of 
Neurological Disorders and Stroke (NINDS) in organiz- 
ing and guiding the monitoring committee for NASCET. 
The consultants looked specifically at the question of 
whether the results of the trial were jeopardized because of 
the issues raised by Dr. Strandness, and found that they 
were not. They also found no evidence of misconduct by 
the NINDS staff. The consultants emphasized, however, 
that several aspects of the way that the data monitoring 
committee for NASCET has been operated could be 
improved, and suggested that NINDS review the proce- 
dures by which we organize and guide data- and safety- 
monitoring committees. As a result, NINDS is now 
formulating a new set of guidelines for these procedures. 
These guidelines will be made available to the research 
community when they are completed. We are grateful to 
Dr. Strandness for raising these issues and hope that we will 
be able to serve the clinical research community even more 
effectively as a result of these changes. 
Zach W. Hall, PhD 
National Institute of Neurological Disorders and Stroke 
Bldg. 31, Rm. 8A52 
Bethesda, MD 20892 
24/41/69637 
Editors" Comments 
These two letters conclude what has been perceived as 
a very vexing problem that faces investigators participating 
in clinical research initiatives that involve patients with 
vascular diseases. The Editors particularly appreciate Dr. 
Hall's response, which notes that NINDS is "formulating 
a new set of guidelines" to address the concerns that Dr. 
Strandness expressed in his special communication i the 
January 1995 issue of the Journal of Vascular Surgery. 
Calvin B. Ernst, MD 
James C. Stanley, MD 
Editors 
